Clinical Trial Update: A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults [Phase 1, Phase 2]

View source ↗

Summary

GlaxoSmithKline conducted a Phase 1/2 trial to assess safety and immune response to multiple doses of a cytomegalovirus vaccine in healthy adults. The study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Cytomegalovirus vaccine (cytomegalovirus vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cytomegalovirus Infections | Phase 1, Phase 2 | Status: COMPLETED